- Home
- TXMD vs HTCR Comparison
TXMD vs HTCR Comparison
Compare TXMD & HTCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TXMD
- HTCR
- Stock Information
- Founded
- TXMD 2008
- HTCR 2009
- Country
- TXMD United States
- HTCR Japan
- Employees
- TXMD N/A
- HTCR N/A
- Industry
- TXMD Biotechnology: Pharmaceutical Preparations
- HTCR EDP Services
- Sector
- TXMD Health Care
- HTCR Technology
- Exchange
- TXMD Nasdaq
- HTCR Nasdaq
- Market Cap
- TXMD 12.7M
- HTCR 11.6M
- IPO Year
- TXMD N/A
- HTCR 2022
- Fundamental
- Price
- TXMD $1.17
- HTCR $0.51
- Analyst Decision
- TXMD
- HTCR
- Analyst Count
- TXMD 0
- HTCR 0
- Target Price
- TXMD N/A
- HTCR N/A
- AVG Volume (30 Days)
- TXMD 23.3K
- HTCR 91.2K
- Earning Date
- TXMD 08-12-2025
- HTCR 08-13-2025
- Dividend Yield
- TXMD N/A
- HTCR 4.00%
- EPS Growth
- TXMD N/A
- HTCR N/A
- EPS
- TXMD N/A
- HTCR N/A
- Revenue
- TXMD $1,841,000.00
- HTCR $28,947,523.00
- Revenue This Year
- TXMD $427.09
- HTCR N/A
- Revenue Next Year
- TXMD N/A
- HTCR $8.59
- P/E Ratio
- TXMD N/A
- HTCR N/A
- Revenue Growth
- TXMD 53.55
- HTCR 59.42
- 52 Week Low
- TXMD $0.70
- HTCR $0.39
- 52 Week High
- TXMD $2.44
- HTCR $3.38
- Technical
- Relative Strength Index (RSI)
- TXMD 54.93
- HTCR 56.25
- Support Level
- TXMD $1.06
- HTCR $0.45
- Resistance Level
- TXMD $1.12
- HTCR $0.50
- Average True Range (ATR)
- TXMD 0.04
- HTCR 0.04
- MACD
- TXMD 0.01
- HTCR 0.00
- Stochastic Oscillator
- TXMD 73.27
- HTCR 52.14
About TXMD TherapeuticsMD Inc.
TherapeuticsMD Inc is a pharmaceutical royalty company, currently receiving royalties on products licensed to pharmaceutical organizations that possess commercial capabilities in the relevant territories. The company and its subsidiaries (i) granted Mayne Pharma an exclusive license to commercialize its IMVEXXY, BIJUVA and prescription prenatal vitamin products sold under the BocaGreenMD and vitaMedMD brands (collectively, the "Licensed Products") in the United States and its possessions and territories, (ii) assigned to Mayne Pharma its exclusive license to commercialize ANNOVERA (together with the Licensed Products, collectively, the "Products") in the United States and its possessions and territories.
About HTCR Heartcore Enterprises Inc.
HeartCore Enterprises Inc is a software development company. The company provides software through two business units. The first business unit includes a customer experience management business. The customer experience management platform includes marketing, sales, service, and content management systems, as well as other tools and integrations that enable companies to attract and engage customers throughout the customer experience. It also provides education, services and support to help customers be successful with the CXM Platform. The second business unit, DX division, is a digital transformation business that provides customers with robotics process automation, process mining, and task mining to accelerate the digital transformation of enterprises.